Miguel Coego Rios
Directeur Financier/CFO chez CENTOGENE N.V.
Postes actifs de Miguel Coego Rios
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CENTOGENE N.V. | Directeur Financier/CFO | 31/03/2022 | - |
| Conseiller Juridique Général | 08/02/2022 | - |
Historique de carrière de Miguel Coego Rios
Anciens postes connus de Miguel Coego Rios
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SHIRE | Corporate Officer/Principal | 01/01/2011 | 01/01/2019 |
Mundipharma International Ltd.
 Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - | - |
| ORPHAZYME A/S | Corporate Officer/Principal | - | - |
Statistiques
Internationale
| Allemagne | 2 |
| Danemark | 2 |
| Royaume-Uni | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Director of Finance/CFO | 1 |
| General Counsel | 1 |
Sectorielle
| Health Technology | 4 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CENTOGENE N.V. | Commercial Services |
| ORPHAZYME A/S | Health Technology |
| Entreprise privées | 2 |
|---|---|
Mundipharma International Ltd.
Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
- Bourse
- Insiders
- Miguel Coego Rios
- Expérience